Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Aegerion Pharmaceuticals Inc (NASDAQ:AEGR)

During the Trading Day
17.70 -0.06 / -0.34%
As of 3:59pm ET
Day’s Change
During After-Hours   Switch to standard view »
17.70 -0.0021 / -0.01%
 
Volume: 4.5K

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Quarter
Trend
Quarter 3
2014
Quarter 4
2014
Quarter 1
2015
Quarter 2
2015
Revenue and IncomeNet Revenues43.7M51.7M59.4M64.2M
 
 
 
 
 
Cost of Goods Sold3.5M3.4M6.2M8.7M
 
 
 
 
 
Depreciation And Amortization276.0K413.0K5.6M5.3M
 
 
 
 
 
 
Operating ExpensesGross Income39.9M47.9M47.5M50.2M
 
 
 
 
 
General Expenses41.9M47.9M56.7M55.1M
 
 
 
 
 
Research And Development10.4M10.7M9.8M12.5M
 
 
 
 
 
Total Operating Expenses45.7M51.6M68.6M69.1M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-2.0M76.0K-9.2M-4.9M
 
 
 
 
 
Extraordinary Charge-2.0K-1.0K0.000.00
 
 
 
Interest Expense On Debt3.2M6.4M6.9M7.1M
 
 
 
 
 
Other Expenses-511.0K-1.4M485.0K1.1M
 
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-5.7M-7.7M-15.6M-10.9M
 
 
 
 
 
Income Taxes-198.0K-372.0K-199.0K-254.0K
 
 
 
 
 
Net Income-5.9M-8.1M-15.8M-11.2M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS29.0M28.4M28.5M28.6M
 
 
 
 
 
Shares To Calculate EPS Diluted29.0M28.4M28.5M28.6M
 
 
 
 
 
 
Earnings Per ShareEPS-$0.20-$0.29-$0.55-$0.39
 
 
 
 
 
EPS Diluted-$0.20-$0.29-$0.55-$0.39